Vnitr Lek 2017, 63(7-8):531-534 | DOI: 10.36290/vnl.2017.108

Viral hepatitis C and organ transplantation

Libuše Husová*, Vladimír Mejzlík
Centrum kardiovaskulární a transplantační chirurgie, Brno

At the Centre for Cardiovascular and Transplantation Surgery, Brno (CKTCH), a total of 638 liver transplantations were performed from the beginning of the transplantation programme on 2/2 1983 to 1/1 2017. Of the overall number of 638 transplantations indicated based on cirrhosis with chronic hepatitis C (HCV), 68 patients (11 %) underwent liver transplantation. Patients with HCV diagnosis were treated both while on the waiting list and after liver transplantation (LT). There was interferon as well as interferon-free therapy used during the treatment. 15 patients received interferon therapy after LT with only 2 of them achieving a sustained virological response 2/15 (13 %). 28 patients received interferon-free therapy after LT. A sustained virological response (SVR 12) was reached by 26/28 (93 %) patients.

Keywords: liver transplantation; viral hepatitis C

Received: May 29, 2017; Accepted: June 20, 2017; Published: July 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husová L, Mejzlík V. Viral hepatitis C and organ transplantation. Vnitr Lek. 2017;63(7-8):531-534. doi: 10.36290/vnl.2017.108.
Download citation

References

  1. Feld JJ, Kowdley KV, Coakley E et al. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014; 370(17): 1594-1603. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1315722>. Go to original source... Go to PubMed...
  2. [European Association for the Study of Liver]. EASL recommendations on treatment of hepatitis C 2014. J Hepatol 2014; 60(2): 392-420. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2013.11.003>. Erratum in: J Hepatol 2014; 61(1): 183-184. Go to original source... Go to PubMed...
  3. [European Association for the Study of Liver]. EASL recommendations on treatment of hepatitis C 2015. J Hepatol 2015; 63(1): 199-236. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2015.03.025>. Go to original source... Go to PubMed...
  4. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol 2017; 66(1): 153-194. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jhep.2016.09.001>.Dostupné z WWW: <http://www.easl.eu/medias/cpg/HCV2016/Summary.pdf>.
  5. AASLD recommendation for testing, managing, and treating hepatitis C. Dostupné z www: <http://www.hcvguidelines.org>.
  6. Urbánek P, Husa P, Šperl J et al. Standardní diagnostický a terapeutický postup chronické infekce virem hepatitidy C (HCV) 2017. Dostupné z WWW: <http://www.ces-hep.cz/file/447/2017-guidelines-hcv.pdf>.
  7. Kwo PY, Mantry PS, Coakley EC at al. An Interferon-free Antiviral Regimen for HCV after Liver Transplantation. N Engl J Med. 2014; 371(25): 2375-2382. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1408921>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.